2-Mercapto N-(azolyl)benzenesulfonamides. VI. Synthesis and anti-HIV activity of some new 2-mercapto-N-(1,2,4-triazol-3-yl)benzenesulfonamide derivatives containing the 1,2,4-triazole moiety fused with a variety of heteroaromatic rings

Acta Poloniae Pharmaceutica - Drug Research

Volumn 55, Issue 6, 1998, Pages 473-480

  Brzozowski, ZdzislŁaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

2 Mercapto N (1,2,4 triazol 3 yl)benzenesulfonamide derivatives; Anti HIV mutants activity; Anti HIV 1 activity; Syntheses

Indexed keywords

AROMATIC COMPOUND; BENZENESULFONAMIDE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; VIRUS MUTANT;

ANTI-HIV AGENTS; CHEMISTRY, PHYSICAL; DRUG RESISTANCE, MICROBIAL; HIV-1; HIV-2; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; SPECTROPHOTOMETRY, INFRARED; SULFONAMIDES; TRIAZOLES; ZIDOVUDINE;

EID: 0032408068     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mohan P., Singh R., Baba M.: J. Med. Chem. 34, 312 (1991).
2. Mohan P., Singh R., Baba M.: Biochem. Pharmacol. 41, 642 (1992).
3. Tan T.G., Wickramasighe A., Verma S., Singh R., Hughes S.H., Pezzuto I.M., Mohan P.: J. Med. Chem. 35, 4846 (1992).
4. Mohan P., Wong M.F., Verma S., Huang P.P., Wickramasinghe A., Baba M.: J. Med. Chem. 36, 1996 (1993).
5. Miyasaka T.,Tanaka M., Baba M.: J. Med. Chem. 32, 2507 (1989).
6. Abdel-Rahman R.M., Seada M., Fawzy M., El.-Baz I.: Pharmazie 49, 729 (1994).
7. McMahon J.B., Gulakowski R.S., Wieslow O.S., Schultz R.J., Narayanan V.I., Clanton D.J., Pedemonte R., Wassmund F.W., Buckheit R.W., Decker C.D., Whitel L., Bader J.P.: Antimicrob. Agents Chemother. 37, 754 (1993).
8. Wiliams T.M., Ciccarone T.M., Mac Taugh S.C., Rooney C.S., Balani S.K., Condra J.H., Emini E.A., Goldman M.E., Greenlee W.J., Kauffman L.R., O'Brien J.A., Sardana V.V., Schleif W.A., Theoharides A.D., Andreson P.S.: J. Med. Chem. 36, 1291 (1993).
9. Yong S.D., Amblard M.C., Britcher S.F., Grey V.E., Tran L.O., Lumma W.C., Huff J.R., Schleif W.A., Emini E.E., O'Brien J.A., Pettibone D.J.: Bioorg. Med. Chem. Lett. 5, 491 (1995).
10. Artico M., Silvestri R., Stefancich G.: Arch. Pharm. (Weinheim) 328, 223 (1995).
11. Artico M., Silvestri R., Mass S., Loi A.G., Corrias S., Piras G., Colla P.: J. Med. Chem. 39, 522 (1996).
12. Brzozowski A.: Acta Polon. Pharm. - Drug Research 52, 91 (1995).
13. Brzozowski Z.: Acta Polon. Pharm. - Drug Research 54, 293 (1997).
14. Brzozowski Z.: Acta Polon. Pharm. - Drug Research 55, 49 (1998).
15. Brzozowski Z.: Acta Polon. Pharm. - Drug Research 55, 233 (1998).
16. Wieslow O.W., Kiser R., Fine D., Bader J., Shoemaker R.H., Boyd M.R.: J. Natl. Cancer Inst. 81, 577 (1989).
17. Brzozowski Z., Sławiński J.: Acta Polon. Pharm. 41, 133 (1984).